Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo

Journal of Virology

Volumn 75, Issue 21, 2001, Pages 10348-10358

  Nijhara, R ^a   Jana, S S ^a   Goswami, S K ^a   Rana, A ^a   Majumdar, S S ^a   Kumar, V ^a   Sarkar, D P ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; HEPATITIS B VIRUS; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; ENZYME ACTIVATION; FEMALE; FLAVONOIDS; HEPATOCYTES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER NEOPLASMS; MAP KINASE KINASE 4; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-JUN; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1;

EID: 0034785734     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.21.10348-10358.2001     Document Type: Article

References (68)

1. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
2. The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis
3. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
4. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen-activated protein kinases and JAK/STAT pathways
5. The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements
6. Hemagglutinin-neuraminidase enhances F protein-mediated membrane fusion of reconstituted Sendai virus envelopes with cells
7. Fusion-mediated microinjection of lysozyme into HepG2 cells through hemagglutinin neuraminidase-depleted Sendai virus envelopes
8. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: A role in the control of cyclin D1 expression
9. Hepatitis B virus HBx protein deregulates cell-cycle checkpoint controls
10. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Res, Raf, MAP kinase signaling cascade
11. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases
12. The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfeeted cell lines
13. ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF
14. Trans-activation of cellular genes by hepatitis B virus proteins: A possible mechanism of hepatocarcinogenesis
15. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
16. Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and wood-chuck hepatocellular carcinomas which are permissive for viral replication
17. Signal transduction by the JNK group of MAP kinases
18. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors
19. The molecular biology of the hepatitis B viruses
20. Hepatitis B virus X protein transcription activation domains are neither required nor sufficient for cell transformation
21. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA
22. Ageing changes in CD1 Ham/ICR mice treated under standard laboratory conditions
23. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
24. Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human heptocellular carcinoma
25. Hepatitis B virus X protein produced in Escherichia coli is biologically functional
26. The regulation of AP-1 activity by mitogen-activated protein kinases
27. Hepatitis B virus transactivator HBx uses a tumor promoter signaling pathway
28. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator
29. HBx gene of hepatitis B virus induces liver cancer in transgenic mice
30. Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras
31. Diverse mitogenic agents induce rapid phosphorylation of a common set of cellular proteins at tyrosine in quiescent mammalian cells
32. Biochemistry and functions of hepatitis B virus X protein
33. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts
34. Meaningful relationships: The regulation of the Ras/Raf/MEK/ERK pathway by protein interactions
35. 1 transition and during exponential growth in mouse fibroblasts: Differential rode of Fos proteins
36. Viral proteins that regulate cellular signaling
37. A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function
38. Functional activity of myogenic HLH protein requires hetero-oligomerization with E12/E47 like protein in vivo
39. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice
40. HBx protein of hepatitis B virus activates Jak1-STAT signaling
41. Signal transduction through MAP kinases cascades
42. Mitogen-activated protein kinase cascade in breast cancer
43. Regulation of interleukin-8 receptor expression in human polymorphonuclear neutrophils
44. Transformation of mammalian cells by constitutively active MAP kinase kinase
45. Signaling networks that cause cancer
46. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK
47. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases
48. Hepatitis B virus X protein: Structure, function and biology
49. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases
50. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249
51. Treatment of mice with EGF and orthovandate activates cytoplasmic and nuclear MAPK, p70S6k, and p90rsk in the liver
52. Phosphorylation of c-Jun mediated by MAP kinases
53. Site-specific gene delivery in vivo through engineered Sendai viral envelopes
54. The hepatitis B virus X protein transactivates viral core gene expression in vivo
55. Mitogen-activated protein kinase pathways
56. Integrated hepatitis B virus X and 3′ truncated preS/S sequences derived from human hepatomas encode functionally active transactivators
57. Increased MAPK expression and activity in primary human hepatocellular carcinoma
58. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73
59. 1 phase progression in proliferating hepatocytes
60. Differential immediate early gene expression in conditional hepatitis B virus pX-transforming versus nontransforming hepatocyte cell lines
61. The hepatitis B virus
62. Endogeneous AP-1 levels necessary for oncogenic activity are higher than those sufficient to support normal growth
63. Induction of cytosolic phospholipase A2 by oncogenic Ras is mediated through the JNK and ERK pathways in rat epithelial cells
64. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms
65. Ras-induced transformation and signaling pathway
66. Antitumor promotion by phenolic antioxidants: Inhibition of AP-1 activity through induction of Fra expression
67. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion